Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immunoglobulin Class Switching | 77 | 2022 | 291 | 12.850 |
Why?
|
Immunoglobulin Heavy Chains | 115 | 2022 | 659 | 12.270 |
Why?
|
B-Lymphocytes | 202 | 2024 | 4666 | 8.870 |
Why?
|
Recombination, Genetic | 117 | 2018 | 1586 | 7.610 |
Why?
|
Cytidine Deaminase | 39 | 2023 | 252 | 6.010 |
Why?
|
DNA Breaks, Double-Stranded | 38 | 2022 | 594 | 5.920 |
Why?
|
Genes, Immunoglobulin | 66 | 2014 | 291 | 5.500 |
Why?
|
Immunoglobulin Variable Region | 65 | 2023 | 421 | 5.450 |
Why?
|
DNA Repair | 70 | 2018 | 2046 | 4.950 |
Why?
|
DNA-Binding Proteins | 136 | 2022 | 9647 | 4.720 |
Why?
|
Translocation, Genetic | 40 | 2018 | 1420 | 4.690 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 21 | 2023 | 97 | 3.930 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 24 | 2014 | 111 | 3.190 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 23 | 2013 | 92 | 2.900 |
Why?
|
Regulatory Sequences, Nucleic Acid | 15 | 2023 | 794 | 2.820 |
Why?
|
Mice | 419 | 2024 | 81201 | 2.620 |
Why?
|
Receptors, Antigen, B-Cell | 19 | 2022 | 548 | 2.540 |
Why?
|
Antigens, Nuclear | 18 | 2010 | 192 | 2.520 |
Why?
|
Homeodomain Proteins | 32 | 2021 | 2418 | 2.490 |
Why?
|
Immunoglobulin Switch Region | 19 | 2017 | 46 | 2.440 |
Why?
|
VDJ Recombinases | 30 | 2011 | 84 | 2.430 |
Why?
|
Genomic Instability | 24 | 2020 | 695 | 2.360 |
Why?
|
Transcription, Genetic | 72 | 2021 | 7721 | 2.170 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 24 | 2019 | 805 | 2.120 |
Why?
|
Animals | 480 | 2024 | 168768 | 2.090 |
Why?
|
Genes, myc | 21 | 2016 | 399 | 2.070 |
Why?
|
T-Lymphocytes | 86 | 2019 | 10183 | 2.020 |
Why?
|
Lymphocytes | 41 | 2013 | 2617 | 1.960 |
Why?
|
DNA Ligases | 14 | 2010 | 80 | 1.960 |
Why?
|
DNA-Activated Protein Kinase | 17 | 2018 | 117 | 1.890 |
Why?
|
Precursor Cells, B-Lymphoid | 12 | 2023 | 98 | 1.850 |
Why?
|
DNA Damage | 34 | 2018 | 2432 | 1.830 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 12 | 2016 | 343 | 1.790 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 11 | 2020 | 57 | 1.760 |
Why?
|
Enhancer Elements, Genetic | 33 | 2021 | 1340 | 1.740 |
Why?
|
Lymphoma, B-Cell | 15 | 2015 | 931 | 1.720 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 14 | 2008 | 97 | 1.720 |
Why?
|
Endonucleases | 11 | 2021 | 380 | 1.700 |
Why?
|
Nuclear Proteins | 49 | 2021 | 5856 | 1.700 |
Why?
|
Chromatin | 20 | 2023 | 2933 | 1.690 |
Why?
|
HIV Antibodies | 11 | 2022 | 1322 | 1.620 |
Why?
|
Sirtuins | 17 | 2013 | 323 | 1.600 |
Why?
|
Antibody Affinity | 3 | 2021 | 254 | 1.590 |
Why?
|
Cell Cycle Proteins | 30 | 2020 | 3464 | 1.530 |
Why?
|
VDJ Exons | 6 | 2015 | 11 | 1.510 |
Why?
|
Immunoglobulin mu-Chains | 18 | 2011 | 62 | 1.470 |
Why?
|
DNA Helicases | 16 | 2004 | 861 | 1.450 |
Why?
|
Proto-Oncogene Proteins c-myc | 27 | 2018 | 988 | 1.440 |
Why?
|
Tumor Suppressor Protein p53 | 28 | 2018 | 2949 | 1.430 |
Why?
|
Neural Stem Cells | 6 | 2020 | 851 | 1.350 |
Why?
|
Tumor Suppressor Proteins | 21 | 2017 | 2850 | 1.330 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 15 | 2009 | 113 | 1.320 |
Why?
|
Immunoglobulin Light Chains | 20 | 2021 | 277 | 1.320 |
Why?
|
Chromosomes, Mammalian | 7 | 2015 | 151 | 1.320 |
Why?
|
Base Sequence | 113 | 2013 | 12797 | 1.300 |
Why?
|
Mice, Knockout | 97 | 2024 | 14561 | 1.290 |
Why?
|
Allergy and Immunology | 3 | 2019 | 169 | 1.280 |
Why?
|
DNA Nucleotidyltransferases | 22 | 2003 | 193 | 1.250 |
Why?
|
Histones | 23 | 2014 | 2598 | 1.240 |
Why?
|
Genes, RAG-1 | 12 | 2018 | 68 | 1.210 |
Why?
|
Antibodies, Neutralizing | 10 | 2022 | 1978 | 1.190 |
Why?
|
Immunoglobulin kappa-Chains | 22 | 2009 | 173 | 1.180 |
Why?
|
AIDS Vaccines | 8 | 2022 | 938 | 1.170 |
Why?
|
Genome | 15 | 2021 | 1807 | 1.130 |
Why?
|
Cell Line | 87 | 2021 | 16000 | 1.130 |
Why?
|
Immunoglobulin Constant Regions | 10 | 2015 | 60 | 1.120 |
Why?
|
DNA | 55 | 2023 | 7294 | 1.090 |
Why?
|
Cell Differentiation | 68 | 2020 | 11486 | 1.080 |
Why?
|
Antibodies | 12 | 2023 | 2460 | 1.080 |
Why?
|
Immunoglobulins | 19 | 2021 | 881 | 1.050 |
Why?
|
Antibody Diversity | 17 | 2021 | 74 | 1.040 |
Why?
|
HIV-1 | 11 | 2022 | 6939 | 1.010 |
Why?
|
Germinal Center | 7 | 2024 | 377 | 1.000 |
Why?
|
Receptors, Antigen, T-Cell | 31 | 2018 | 2540 | 0.980 |
Why?
|
Gene Expression Regulation | 66 | 2021 | 12073 | 0.980 |
Why?
|
Gene Amplification | 15 | 2018 | 1063 | 0.980 |
Why?
|
Gene Rearrangement | 31 | 2022 | 1179 | 0.970 |
Why?
|
Sequence Deletion | 17 | 2019 | 1525 | 0.940 |
Why?
|
Cells, Cultured | 69 | 2021 | 19233 | 0.940 |
Why?
|
Chromosome Breakage | 7 | 2013 | 173 | 0.940 |
Why?
|
Molecular Sequence Data | 90 | 2015 | 18111 | 0.910 |
Why?
|
Lymphoma | 20 | 2015 | 1877 | 0.910 |
Why?
|
Mice, Transgenic | 60 | 2021 | 9735 | 0.910 |
Why?
|
Genes, p53 | 5 | 2020 | 755 | 0.900 |
Why?
|
Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 5 | 2016 | 16 | 0.900 |
Why?
|
Mice, Mutant Strains | 36 | 2019 | 1865 | 0.820 |
Why?
|
Models, Immunological | 7 | 2015 | 527 | 0.810 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 4 | 2022 | 371 | 0.800 |
Why?
|
Immunoglobulin M | 15 | 2016 | 1537 | 0.790 |
Why?
|
Chromosomal Proteins, Non-Histone | 7 | 2020 | 735 | 0.790 |
Why?
|
Immunoglobulin Joining Region | 12 | 2012 | 36 | 0.790 |
Why?
|
Embryonic Stem Cells | 14 | 2020 | 1295 | 0.790 |
Why?
|
Genes, T-Cell Receptor beta | 4 | 2008 | 71 | 0.790 |
Why?
|
Oncogenes | 14 | 2009 | 1265 | 0.790 |
Why?
|
Cell Transformation, Viral | 15 | 2015 | 567 | 0.780 |
Why?
|
Proteins | 34 | 2021 | 6100 | 0.770 |
Why?
|
Embryo, Mammalian | 21 | 2013 | 1701 | 0.760 |
Why?
|
DNA, Intergenic | 4 | 2018 | 107 | 0.760 |
Why?
|
Proto-Oncogenes | 15 | 2006 | 321 | 0.750 |
Why?
|
Blotting, Southern | 20 | 2015 | 803 | 0.740 |
Why?
|
Peyer's Patches | 3 | 2020 | 121 | 0.740 |
Why?
|
Blastocyst | 10 | 2020 | 424 | 0.740 |
Why?
|
Thymus Neoplasms | 7 | 2010 | 268 | 0.740 |
Why?
|
Chimera | 25 | 2020 | 485 | 0.730 |
Why?
|
Mammals | 6 | 2018 | 1143 | 0.730 |
Why?
|
Mutagenesis | 11 | 2018 | 1264 | 0.710 |
Why?
|
Proto-Oncogene Proteins | 30 | 2006 | 4554 | 0.700 |
Why?
|
RNA, Antisense | 3 | 2016 | 138 | 0.700 |
Why?
|
Gene Targeting | 19 | 2016 | 880 | 0.700 |
Why?
|
HIV Seropositivity | 2 | 2022 | 971 | 0.700 |
Why?
|
Flow Cytometry | 38 | 2016 | 5974 | 0.680 |
Why?
|
Lymphocyte Activation | 32 | 2021 | 5524 | 0.660 |
Why?
|
Nucleic Acid Conformation | 3 | 2021 | 913 | 0.660 |
Why?
|
Chromosomes | 8 | 2016 | 596 | 0.650 |
Why?
|
Mice, Inbred C57BL | 58 | 2021 | 21833 | 0.650 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Light Chain | 6 | 2007 | 18 | 0.650 |
Why?
|
Alleles | 41 | 2013 | 6933 | 0.640 |
Why?
|
Mutation | 51 | 2023 | 29786 | 0.640 |
Why?
|
Organogenesis | 2 | 2020 | 222 | 0.620 |
Why?
|
Hybridomas | 21 | 2010 | 452 | 0.610 |
Why?
|
Severe Combined Immunodeficiency | 9 | 2013 | 223 | 0.600 |
Why?
|
Multigene Family | 13 | 2020 | 1102 | 0.600 |
Why?
|
Immunoglobulin E | 6 | 2011 | 1463 | 0.600 |
Why?
|
DNA Primers | 18 | 2014 | 2891 | 0.580 |
Why?
|
Gene Deletion | 19 | 2018 | 2751 | 0.570 |
Why?
|
Immunoglobulin epsilon-Chains | 4 | 2011 | 16 | 0.570 |
Why?
|
Prosencephalon | 1 | 2018 | 303 | 0.560 |
Why?
|
Genes | 21 | 1988 | 1893 | 0.540 |
Why?
|
Actins | 9 | 2012 | 2121 | 0.540 |
Why?
|
Genetic Techniques | 2 | 2016 | 435 | 0.540 |
Why?
|
Receptors, Antigen | 6 | 2012 | 53 | 0.530 |
Why?
|
Immunoglobulin Isotypes | 9 | 2022 | 158 | 0.530 |
Why?
|
Cell Lineage | 12 | 2016 | 2504 | 0.530 |
Why?
|
DNA Breaks | 3 | 2021 | 49 | 0.520 |
Why?
|
Neurogenesis | 2 | 2020 | 838 | 0.520 |
Why?
|
B-Lymphocyte Subsets | 7 | 2021 | 246 | 0.520 |
Why?
|
Immunologic Deficiency Syndromes | 11 | 2010 | 547 | 0.510 |
Why?
|
Immunization | 6 | 2016 | 1256 | 0.510 |
Why?
|
DNA Repair Enzymes | 4 | 2016 | 349 | 0.510 |
Why?
|
Thymus Gland | 20 | 2011 | 1267 | 0.500 |
Why?
|
DNA Nucleotidylexotransferase | 5 | 2022 | 64 | 0.500 |
Why?
|
Repressor Proteins | 10 | 2016 | 3024 | 0.500 |
Why?
|
Deoxyribonuclease I | 7 | 2013 | 229 | 0.490 |
Why?
|
Genes, T-Cell Receptor delta | 3 | 2009 | 11 | 0.490 |
Why?
|
Cloning, Molecular | 28 | 2004 | 4320 | 0.480 |
Why?
|
Introns | 12 | 2009 | 992 | 0.480 |
Why?
|
Viral Matrix Proteins | 1 | 2015 | 186 | 0.480 |
Why?
|
Fibroblasts | 30 | 2018 | 4162 | 0.480 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2017 | 693 | 0.480 |
Why?
|
Genes, T-Cell Receptor alpha | 3 | 2009 | 19 | 0.480 |
Why?
|
Vaccines | 1 | 2022 | 823 | 0.470 |
Why?
|
Serine | 6 | 2013 | 826 | 0.470 |
Why?
|
Stem Cells | 27 | 2006 | 3567 | 0.470 |
Why?
|
Deamination | 6 | 2015 | 26 | 0.460 |
Why?
|
Spleen | 23 | 2017 | 2362 | 0.460 |
Why?
|
Genes, Lethal | 7 | 2006 | 242 | 0.450 |
Why?
|
Amino Acid Sequence | 41 | 2015 | 13814 | 0.450 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 4 | 2014 | 170 | 0.440 |
Why?
|
Genetic Complementation Test | 13 | 2018 | 562 | 0.440 |
Why?
|
Transcription Factors | 31 | 2016 | 12207 | 0.440 |
Why?
|
Abelson murine leukemia virus | 19 | 1993 | 43 | 0.440 |
Why?
|
Immunoglobulin G | 14 | 2018 | 4561 | 0.430 |
Why?
|
Radiation Tolerance | 8 | 2013 | 486 | 0.430 |
Why?
|
Cell Transformation, Neoplastic | 18 | 2008 | 2943 | 0.430 |
Why?
|
High-Throughput Nucleotide Sequencing | 8 | 2021 | 3595 | 0.430 |
Why?
|
Promoter Regions, Genetic | 13 | 2012 | 5867 | 0.420 |
Why?
|
CHO Cells | 14 | 2003 | 1409 | 0.410 |
Why?
|
Receptors, Interleukin-2 | 5 | 1999 | 573 | 0.410 |
Why?
|
Restriction Mapping | 18 | 2009 | 878 | 0.410 |
Why?
|
Polymerase Chain Reaction | 23 | 2016 | 6171 | 0.410 |
Why?
|
In Situ Hybridization, Fluorescence | 12 | 2013 | 2649 | 0.400 |
Why?
|
Chromosome Aberrations | 12 | 2009 | 1813 | 0.400 |
Why?
|
Immunoglobulin J-Chains | 8 | 1997 | 27 | 0.390 |
Why?
|
5' Flanking Region | 1 | 2010 | 31 | 0.390 |
Why?
|
Interleukin-4 | 15 | 2004 | 1147 | 0.390 |
Why?
|
Genes, bcl-2 | 2 | 2004 | 122 | 0.380 |
Why?
|
Cell Cycle | 17 | 2006 | 2967 | 0.370 |
Why?
|
Immunoglobulin lambda-Chains | 8 | 2009 | 87 | 0.370 |
Why?
|
Exoribonucleases | 1 | 2011 | 95 | 0.370 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 10 | 2012 | 160 | 0.370 |
Why?
|
Apoptosis | 28 | 2021 | 9724 | 0.370 |
Why?
|
Radiation, Ionizing | 11 | 2016 | 258 | 0.370 |
Why?
|
Lymphoid Tissue | 7 | 1999 | 455 | 0.370 |
Why?
|
Ataxia Telangiectasia | 5 | 2015 | 112 | 0.360 |
Why?
|
Cell Line, Transformed | 14 | 2010 | 898 | 0.360 |
Why?
|
Growth | 2 | 2010 | 376 | 0.360 |
Why?
|
Lipopolysaccharides | 16 | 2012 | 2216 | 0.360 |
Why?
|
Humans | 190 | 2024 | 744366 | 0.360 |
Why?
|
Complementarity Determining Regions | 4 | 2023 | 149 | 0.360 |
Why?
|
HIV Infections | 7 | 2022 | 16715 | 0.350 |
Why?
|
Protein-Tyrosine Kinases | 12 | 2017 | 2455 | 0.350 |
Why?
|
Genes, Switch | 5 | 2002 | 47 | 0.350 |
Why?
|
Gene Silencing | 4 | 2017 | 1539 | 0.350 |
Why?
|
Orthomyxoviridae | 3 | 2024 | 156 | 0.340 |
Why?
|
Hematopoietic Stem Cells | 14 | 2002 | 3390 | 0.340 |
Why?
|
Models, Genetic | 17 | 2006 | 3493 | 0.340 |
Why?
|
RNA Editing | 3 | 2014 | 148 | 0.340 |
Why?
|
Embryonic and Fetal Development | 4 | 2001 | 438 | 0.340 |
Why?
|
Exons | 10 | 2009 | 2439 | 0.330 |
Why?
|
Phosphorylation | 18 | 2022 | 8436 | 0.330 |
Why?
|
Neurons | 10 | 2020 | 9340 | 0.330 |
Why?
|
ras Proteins | 4 | 1999 | 1060 | 0.330 |
Why?
|
Induced Pluripotent Stem Cells | 4 | 2020 | 1736 | 0.330 |
Why?
|
Transcription Initiation Site | 3 | 2016 | 196 | 0.330 |
Why?
|
Biological Evolution | 3 | 2009 | 1077 | 0.330 |
Why?
|
Chromatids | 3 | 2007 | 63 | 0.320 |
Why?
|
Cricetinae | 16 | 2003 | 2475 | 0.320 |
Why?
|
3' Untranslated Regions | 2 | 2009 | 513 | 0.320 |
Why?
|
DNA, Complementary | 8 | 2004 | 2050 | 0.320 |
Why?
|
Carrier Proteins | 10 | 2013 | 5023 | 0.310 |
Why?
|
Transfection | 23 | 2013 | 5895 | 0.300 |
Why?
|
Locus Control Region | 2 | 2015 | 20 | 0.300 |
Why?
|
Multienzyme Complexes | 1 | 2011 | 686 | 0.300 |
Why?
|
Sirtuin 3 | 4 | 2011 | 68 | 0.300 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 2 | 2008 | 491 | 0.290 |
Why?
|
Down-Regulation | 8 | 2021 | 3001 | 0.290 |
Why?
|
G1 Phase | 5 | 2021 | 415 | 0.290 |
Why?
|
Hypergammaglobulinemia | 2 | 2005 | 74 | 0.290 |
Why?
|
Mice, SCID | 5 | 2002 | 2716 | 0.290 |
Why?
|
Germ-Free Life | 2 | 2020 | 188 | 0.290 |
Why?
|
Immunoglobulin gamma-Chains | 7 | 1998 | 33 | 0.290 |
Why?
|
RNA | 9 | 2011 | 2749 | 0.280 |
Why?
|
Evolution, Molecular | 4 | 2023 | 1939 | 0.280 |
Why?
|
RNA, Messenger | 34 | 2022 | 13035 | 0.280 |
Why?
|
Wiskott-Aldrich Syndrome | 5 | 2003 | 131 | 0.280 |
Why?
|
Neoplasms | 14 | 2014 | 21696 | 0.280 |
Why?
|
History, 20th Century | 5 | 2019 | 2740 | 0.280 |
Why?
|
Bone Marrow Cells | 17 | 2013 | 2513 | 0.280 |
Why?
|
Antibodies, Monoclonal | 14 | 2022 | 9274 | 0.280 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2015 | 8432 | 0.270 |
Why?
|
DNA, Circular | 2 | 2021 | 97 | 0.270 |
Why?
|
Wiskott-Aldrich Syndrome Protein, Neuronal | 5 | 2012 | 88 | 0.270 |
Why?
|
Homozygote | 14 | 2009 | 1787 | 0.270 |
Why?
|
Gene Expression Regulation, Developmental | 12 | 2013 | 3617 | 0.270 |
Why?
|
Hematopoiesis | 12 | 2012 | 2073 | 0.260 |
Why?
|
Mice, Inbred BALB C | 28 | 2012 | 6386 | 0.260 |
Why?
|
Pluripotent Stem Cells | 1 | 2012 | 795 | 0.260 |
Why?
|
Chromosome Pairing | 2 | 2019 | 47 | 0.250 |
Why?
|
Selection, Genetic | 2 | 2020 | 914 | 0.250 |
Why?
|
Genes, T-Cell Receptor | 1 | 2004 | 29 | 0.250 |
Why?
|
Transgenes | 9 | 2014 | 1009 | 0.250 |
Why?
|
T-Lymphocyte Subsets | 7 | 2009 | 1837 | 0.250 |
Why?
|
Phenotype | 22 | 2020 | 16367 | 0.240 |
Why?
|
Xeroderma Pigmentosum | 1 | 2004 | 31 | 0.240 |
Why?
|
Acetylation | 11 | 2011 | 1084 | 0.240 |
Why?
|
Trihexosylceramides | 1 | 2024 | 32 | 0.240 |
Why?
|
Central Nervous System | 4 | 2000 | 1357 | 0.240 |
Why?
|
Cytosine Deaminase | 1 | 2004 | 68 | 0.240 |
Why?
|
Cell Division | 13 | 2004 | 4569 | 0.240 |
Why?
|
Cell Movement | 6 | 2012 | 5218 | 0.240 |
Why?
|
cdc42 GTP-Binding Protein | 3 | 2002 | 193 | 0.230 |
Why?
|
Suppression, Genetic | 1 | 2004 | 196 | 0.230 |
Why?
|
Interleukin-7 | 3 | 1994 | 142 | 0.230 |
Why?
|
Genetic Vectors | 10 | 2015 | 3424 | 0.230 |
Why?
|
Signal Transduction | 32 | 2022 | 23404 | 0.230 |
Why?
|
Disease Models, Animal | 9 | 2021 | 18034 | 0.230 |
Why?
|
Replication Protein A | 4 | 2008 | 52 | 0.230 |
Why?
|
Chromosome Mapping | 16 | 2021 | 4740 | 0.220 |
Why?
|
Enzyme Activation | 5 | 2009 | 3702 | 0.220 |
Why?
|
Neoplasms, Experimental | 3 | 2008 | 1276 | 0.220 |
Why?
|
Sequence Homology, Nucleic Acid | 10 | 2005 | 1085 | 0.220 |
Why?
|
Orthomyxoviridae Infections | 2 | 2024 | 248 | 0.220 |
Why?
|
Leukemia Virus, Murine | 6 | 1995 | 117 | 0.220 |
Why?
|
Cytidine | 1 | 2003 | 68 | 0.220 |
Why?
|
Longevity | 4 | 2009 | 1071 | 0.220 |
Why?
|
rac GTP-Binding Proteins | 1 | 2003 | 164 | 0.220 |
Why?
|
Antibodies, Viral | 3 | 2024 | 3177 | 0.220 |
Why?
|
Cell Surface Extensions | 2 | 2003 | 67 | 0.220 |
Why?
|
Epitopes | 4 | 2022 | 2571 | 0.210 |
Why?
|
Epigenesis, Genetic | 4 | 2012 | 3646 | 0.210 |
Why?
|
Neomycin | 2 | 1999 | 88 | 0.210 |
Why?
|
Recombinant Fusion Proteins | 9 | 2010 | 3773 | 0.210 |
Why?
|
Intestinal Mucosa | 1 | 2013 | 3037 | 0.210 |
Why?
|
Ultraviolet Rays | 2 | 2004 | 1060 | 0.210 |
Why?
|
DNA Fragmentation | 2 | 2021 | 242 | 0.210 |
Why?
|
DNA Replication | 2 | 2020 | 1399 | 0.210 |
Why?
|
Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 2000 | 33 | 0.200 |
Why?
|
Fetal Death | 4 | 2004 | 448 | 0.200 |
Why?
|
Antibody Formation | 9 | 2024 | 1402 | 0.200 |
Why?
|
Histone Deacetylases | 4 | 2008 | 728 | 0.200 |
Why?
|
Saccharomyces cerevisiae Proteins | 5 | 2014 | 1887 | 0.200 |
Why?
|
Gene Expression | 23 | 2021 | 7798 | 0.200 |
Why?
|
Avian Proteins | 1 | 2021 | 80 | 0.200 |
Why?
|
ATP-Binding Cassette Transporters | 2 | 2009 | 560 | 0.200 |
Why?
|
Germ Cells | 2 | 2018 | 631 | 0.200 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2021 | 102 | 0.200 |
Why?
|
Activating Transcription Factor 3 | 1 | 2021 | 54 | 0.200 |
Why?
|
Reactive Oxygen Species | 2 | 2008 | 2076 | 0.190 |
Why?
|
Sirtuin 1 | 9 | 2008 | 246 | 0.190 |
Why?
|
Mitogen-Activated Protein Kinases | 4 | 2003 | 1284 | 0.190 |
Why?
|
Blotting, Northern | 11 | 2000 | 1581 | 0.190 |
Why?
|
Zebrafish | 3 | 2009 | 2996 | 0.190 |
Why?
|
Point Mutation | 4 | 2011 | 1624 | 0.190 |
Why?
|
Tandem Repeat Sequences | 2 | 2022 | 185 | 0.190 |
Why?
|
Genetic Diseases, Inborn | 1 | 2006 | 587 | 0.190 |
Why?
|
Heterozygote | 11 | 2016 | 2804 | 0.190 |
Why?
|
Models, Biological | 15 | 2011 | 9584 | 0.190 |
Why?
|
beta-Lactamases | 1 | 2002 | 306 | 0.190 |
Why?
|
Mutation, Missense | 4 | 2011 | 2566 | 0.190 |
Why?
|
Membrane Fusion | 1 | 2022 | 276 | 0.190 |
Why?
|
Indoleacetic Acids | 1 | 2020 | 44 | 0.190 |
Why?
|
Medulloblastoma | 1 | 2006 | 683 | 0.190 |
Why?
|
Immune System | 4 | 2008 | 806 | 0.190 |
Why?
|
Cytoskeleton | 6 | 2010 | 1185 | 0.190 |
Why?
|
Aging | 11 | 2009 | 8664 | 0.180 |
Why?
|
Phosphatidylinositol 4,5-Diphosphate | 1 | 2000 | 127 | 0.180 |
Why?
|
Chromosomes, Human, Pair 14 | 2 | 2015 | 299 | 0.180 |
Why?
|
DNA, Single-Stranded | 4 | 2023 | 355 | 0.180 |
Why?
|
Burkitt Lymphoma | 1 | 2021 | 327 | 0.170 |
Why?
|
Caloric Restriction | 4 | 2010 | 302 | 0.170 |
Why?
|
Cryoelectron Microscopy | 1 | 2022 | 576 | 0.170 |
Why?
|
Phosphoproteins | 6 | 2006 | 2441 | 0.170 |
Why?
|
Sequence Homology, Amino Acid | 5 | 2009 | 2839 | 0.170 |
Why?
|
Antigens, CD | 8 | 2002 | 4026 | 0.170 |
Why?
|
Substrate Specificity | 5 | 2017 | 1802 | 0.170 |
Why?
|
Genes, Regulator | 4 | 2004 | 378 | 0.170 |
Why?
|
Microtubule-Associated Proteins | 4 | 2018 | 1085 | 0.170 |
Why?
|
Poly(ADP-ribose) Polymerases | 2 | 2018 | 440 | 0.160 |
Why?
|
MAP Kinase Kinase 4 | 2 | 1998 | 148 | 0.160 |
Why?
|
Membrane Glycoproteins | 8 | 2006 | 3771 | 0.160 |
Why?
|
Autoantibodies | 7 | 2010 | 2036 | 0.160 |
Why?
|
Conserved Sequence | 3 | 2009 | 1202 | 0.160 |
Why?
|
Genetic Loci | 3 | 2015 | 2575 | 0.160 |
Why?
|
DNA, Recombinant | 5 | 2005 | 476 | 0.160 |
Why?
|
Germ-Line Mutation | 3 | 2021 | 1788 | 0.160 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 1998 | 647 | 0.160 |
Why?
|
Binding Sites, Antibody | 1 | 2018 | 349 | 0.160 |
Why?
|
Integrases | 5 | 2012 | 533 | 0.160 |
Why?
|
Mitochondria, Liver | 2 | 2009 | 187 | 0.150 |
Why?
|
Rad52 DNA Repair and Recombination Protein | 1 | 2017 | 32 | 0.150 |
Why?
|
Microfilament Proteins | 1 | 2003 | 1152 | 0.150 |
Why?
|
Lymphocyte Subsets | 1 | 1998 | 315 | 0.150 |
Why?
|
Mice, Inbred CBA | 5 | 1999 | 448 | 0.150 |
Why?
|
RNA Polymerase II | 1 | 2021 | 550 | 0.150 |
Why?
|
Protein Sorting Signals | 1 | 2018 | 281 | 0.150 |
Why?
|
Luminescent Proteins | 2 | 2002 | 853 | 0.150 |
Why?
|
Peptide Fragments | 2 | 2008 | 5096 | 0.150 |
Why?
|
Vaccinia virus | 3 | 2012 | 349 | 0.150 |
Why?
|
Cell Compartmentation | 1 | 1998 | 402 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-vav | 9 | 2003 | 95 | 0.150 |
Why?
|
Gene Knock-In Techniques | 5 | 2019 | 418 | 0.150 |
Why?
|
Cell Proliferation | 10 | 2020 | 10483 | 0.150 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2015 | 4751 | 0.150 |
Why?
|
Trans-Activators | 5 | 2008 | 2926 | 0.140 |
Why?
|
Amino Acid Transport Systems, Basic | 1 | 2016 | 32 | 0.140 |
Why?
|
Sensory Receptor Cells | 1 | 2021 | 493 | 0.140 |
Why?
|
Mice, Inbred Strains | 11 | 2011 | 1828 | 0.140 |
Why?
|
Intracellular Signaling Peptides and Proteins | 5 | 2007 | 2916 | 0.140 |
Why?
|
Mutagenesis, Site-Directed | 4 | 2021 | 1723 | 0.140 |
Why?
|
Leukemia, Experimental | 5 | 1991 | 246 | 0.140 |
Why?
|
Immunophenotyping | 5 | 2015 | 1880 | 0.140 |
Why?
|
Lymphoma, T-Cell | 3 | 2015 | 299 | 0.140 |
Why?
|
Wilms Tumor | 3 | 1988 | 373 | 0.140 |
Why?
|
Genes, Homeobox | 2 | 1997 | 286 | 0.130 |
Why?
|
Lysine | 3 | 2010 | 1007 | 0.130 |
Why?
|
Protein Binding | 8 | 2017 | 9384 | 0.130 |
Why?
|
Genotype | 7 | 2015 | 12952 | 0.130 |
Why?
|
Homeostasis | 4 | 2020 | 3339 | 0.130 |
Why?
|
Receptors, IgE | 5 | 2003 | 389 | 0.130 |
Why?
|
Inhibitory Concentration 50 | 1 | 2016 | 459 | 0.130 |
Why?
|
Mutagenesis, Insertional | 3 | 2008 | 655 | 0.130 |
Why?
|
Chromosomal Instability | 2 | 2009 | 183 | 0.130 |
Why?
|
Sequence Alignment | 5 | 2008 | 2256 | 0.130 |
Why?
|
Clone Cells | 6 | 2010 | 1692 | 0.130 |
Why?
|
Lentivirus | 2 | 2010 | 503 | 0.130 |
Why?
|
beta-Globins | 1 | 2015 | 115 | 0.130 |
Why?
|
Nerve Tissue Proteins | 4 | 2016 | 4463 | 0.130 |
Why?
|
Cricetulus | 2 | 1996 | 818 | 0.130 |
Why?
|
Agammaglobulinemia | 4 | 1998 | 167 | 0.130 |
Why?
|
Liver | 17 | 2010 | 7475 | 0.130 |
Why?
|
Epistasis, Genetic | 1 | 2017 | 365 | 0.130 |
Why?
|
Neocortex | 1 | 2018 | 400 | 0.120 |
Why?
|
Organ Specificity | 4 | 2012 | 2008 | 0.120 |
Why?
|
YY1 Transcription Factor | 2 | 2013 | 60 | 0.120 |
Why?
|
Immunologic Surveillance | 1 | 2015 | 93 | 0.120 |
Why?
|
Telomere | 4 | 2007 | 910 | 0.120 |
Why?
|
Frameshift Mutation | 1 | 1996 | 399 | 0.120 |
Why?
|
Genes, jun | 1 | 1994 | 71 | 0.120 |
Why?
|
Lectins | 1 | 1997 | 513 | 0.120 |
Why?
|
Amination | 2 | 2004 | 19 | 0.120 |
Why?
|
Gene Knockout Techniques | 2 | 2015 | 808 | 0.120 |
Why?
|
CD4-Positive T-Lymphocytes | 6 | 2007 | 4386 | 0.120 |
Why?
|
Feces | 1 | 2020 | 1401 | 0.120 |
Why?
|
NF-kappa B | 3 | 2015 | 2499 | 0.120 |
Why?
|
Adaptor Proteins, Signal Transducing | 8 | 2012 | 2917 | 0.120 |
Why?
|
Karyotyping | 6 | 2018 | 1243 | 0.120 |
Why?
|
Protein Kinases | 2 | 1998 | 1640 | 0.120 |
Why?
|
Neuroblastoma | 6 | 1988 | 1226 | 0.120 |
Why?
|
Blotting, Western | 9 | 2013 | 5181 | 0.120 |
Why?
|
Interleukins | 2 | 1988 | 791 | 0.120 |
Why?
|
Mast Cells | 5 | 2003 | 1544 | 0.120 |
Why?
|
Lymphopenia | 2 | 2015 | 285 | 0.120 |
Why?
|
Mitochondria | 4 | 2010 | 3514 | 0.120 |
Why?
|
DNA Restriction Enzymes | 9 | 1987 | 570 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 5 | 2008 | 1434 | 0.110 |
Why?
|
Brain | 12 | 2020 | 26388 | 0.110 |
Why?
|
Mitochondrial Proteins | 2 | 2011 | 994 | 0.110 |
Why?
|
Weaning | 1 | 2013 | 105 | 0.110 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2017 | 670 | 0.110 |
Why?
|
Axons | 1 | 2021 | 1685 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 6 | 2014 | 3873 | 0.110 |
Why?
|
Rad51 Recombinase | 3 | 2005 | 189 | 0.110 |
Why?
|
Immunity, Innate | 2 | 2021 | 2962 | 0.110 |
Why?
|
Binding Sites | 8 | 2016 | 6111 | 0.110 |
Why?
|
Macromolecular Substances | 4 | 2004 | 1454 | 0.110 |
Why?
|
Female | 49 | 2020 | 380193 | 0.110 |
Why?
|
Enteropathogenic Escherichia coli | 1 | 2012 | 27 | 0.110 |
Why?
|
Genes, Reporter | 4 | 2017 | 1547 | 0.110 |
Why?
|
Cell Separation | 5 | 2012 | 1751 | 0.110 |
Why?
|
Bone Marrow | 11 | 2000 | 2948 | 0.110 |
Why?
|
Neuropeptides | 1 | 2018 | 942 | 0.110 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 890 | 0.110 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 3 | 2011 | 154 | 0.110 |
Why?
|
Telomere-Binding Proteins | 1 | 2013 | 116 | 0.110 |
Why?
|
Antigens, Surface | 6 | 2016 | 1663 | 0.110 |
Why?
|
Cytogenetic Analysis | 2 | 2010 | 295 | 0.110 |
Why?
|
Immunoglobulin D | 2 | 1999 | 56 | 0.110 |
Why?
|
RNA-Binding Proteins | 2 | 2018 | 1903 | 0.110 |
Why?
|
Myosin Light Chains | 1 | 1992 | 121 | 0.110 |
Why?
|
Plasmids | 4 | 2009 | 2308 | 0.100 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 175 | 0.100 |
Why?
|
RNA Interference | 3 | 2018 | 2890 | 0.100 |
Why?
|
Mesenchymoma | 1 | 1992 | 47 | 0.100 |
Why?
|
Male | 40 | 2021 | 350115 | 0.100 |
Why?
|
Genes, ras | 4 | 2005 | 690 | 0.100 |
Why?
|
Canaries | 1 | 1991 | 6 | 0.100 |
Why?
|
Vaccination | 3 | 2021 | 3279 | 0.100 |
Why?
|
Catalysis | 2 | 2018 | 762 | 0.100 |
Why?
|
Protein Processing, Post-Translational | 3 | 2009 | 1988 | 0.100 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 1992 | 109 | 0.100 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2005 | 705 | 0.100 |
Why?
|
Hydroxymethylglutaryl-CoA Synthase | 1 | 2010 | 16 | 0.100 |
Why?
|
Survival Rate | 8 | 2008 | 12788 | 0.100 |
Why?
|
Oncogene Proteins | 3 | 2012 | 749 | 0.100 |
Why?
|
Protein Engineering | 1 | 2014 | 538 | 0.100 |
Why?
|
BRCA1 Protein | 5 | 2017 | 1149 | 0.100 |
Why?
|
Common Variable Immunodeficiency | 1 | 2011 | 93 | 0.100 |
Why?
|
Models, Molecular | 2 | 2018 | 5451 | 0.100 |
Why?
|
Symbiosis | 1 | 2013 | 287 | 0.100 |
Why?
|
Ketone Bodies | 1 | 2010 | 82 | 0.090 |
Why?
|
Neoplasm Proteins | 2 | 1997 | 3707 | 0.090 |
Why?
|
Chickens | 3 | 2021 | 865 | 0.090 |
Why?
|
Infertility, Male | 3 | 2013 | 409 | 0.090 |
Why?
|
Shigella flexneri | 2 | 2002 | 132 | 0.090 |
Why?
|
Myosins | 1 | 1992 | 409 | 0.090 |
Why?
|
Nucleotides | 1 | 1993 | 464 | 0.090 |
Why?
|
DNA Mutational Analysis | 5 | 2011 | 4185 | 0.090 |
Why?
|
Cytological Techniques | 1 | 2012 | 219 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2020 | 1580 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 6 | 2007 | 4479 | 0.090 |
Why?
|
Cell Adhesion Molecules | 1 | 1997 | 1602 | 0.090 |
Why?
|
src Homology Domains | 3 | 2000 | 364 | 0.090 |
Why?
|
Antibody Specificity | 3 | 2013 | 1095 | 0.090 |
Why?
|
NIH 3T3 Cells | 3 | 2008 | 677 | 0.090 |
Why?
|
MutS Homolog 2 Protein | 1 | 2011 | 200 | 0.090 |
Why?
|
NAD | 3 | 2009 | 590 | 0.090 |
Why?
|
Nanoparticles | 1 | 2022 | 1905 | 0.090 |
Why?
|
Autistic Disorder | 1 | 2020 | 1185 | 0.090 |
Why?
|
Antibody-Producing Cells | 1 | 2010 | 143 | 0.090 |
Why?
|
Glutamate Dehydrogenase | 2 | 2007 | 52 | 0.090 |
Why?
|
Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2010 | 52 | 0.090 |
Why?
|
Chromosome Breakpoints | 1 | 2009 | 98 | 0.090 |
Why?
|
Exodeoxyribonucleases | 1 | 2011 | 180 | 0.090 |
Why?
|
Acid Anhydride Hydrolases | 1 | 2009 | 72 | 0.090 |
Why?
|
Haploinsufficiency | 1 | 2011 | 328 | 0.090 |
Why?
|
Philadelphia Chromosome | 1 | 2010 | 112 | 0.090 |
Why?
|
Saccharomyces cerevisiae | 4 | 2006 | 2751 | 0.090 |
Why?
|
Receptors, Complement 3d | 1 | 2009 | 118 | 0.090 |
Why?
|
Oligodeoxyribonucleotides | 4 | 1994 | 708 | 0.090 |
Why?
|
Mitogens | 4 | 2001 | 232 | 0.080 |
Why?
|
Phosphoglycerate Kinase | 2 | 1999 | 68 | 0.080 |
Why?
|
X Chromosome | 3 | 1995 | 814 | 0.080 |
Why?
|
Granulomatous Disease, Chronic | 1 | 2010 | 174 | 0.080 |
Why?
|
Saccharomycetales | 1 | 2009 | 67 | 0.080 |
Why?
|
Interphase | 1 | 2009 | 226 | 0.080 |
Why?
|
Pseudogenes | 2 | 1991 | 113 | 0.080 |
Why?
|
Cell Survival | 7 | 2015 | 5882 | 0.080 |
Why?
|
Feedback, Physiological | 1 | 2011 | 479 | 0.080 |
Why?
|
Tumor Cells, Cultured | 4 | 2006 | 6313 | 0.080 |
Why?
|
Structure-Activity Relationship | 5 | 2017 | 3130 | 0.080 |
Why?
|
Embryo Loss | 1 | 2008 | 59 | 0.080 |
Why?
|
Obesity | 1 | 2010 | 12746 | 0.080 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 3 | 2003 | 452 | 0.080 |
Why?
|
Metaphase | 2 | 2007 | 151 | 0.080 |
Why?
|
Fetal Viability | 1 | 2008 | 31 | 0.080 |
Why?
|
Sequence Analysis, DNA | 3 | 2015 | 4805 | 0.080 |
Why?
|
Sister Chromatid Exchange | 2 | 2006 | 60 | 0.080 |
Why?
|
DNA Probes | 2 | 2008 | 560 | 0.080 |
Why?
|
Tumor Suppressor Protein p14ARF | 2 | 2005 | 90 | 0.080 |
Why?
|
Species Specificity | 2 | 2009 | 2478 | 0.080 |
Why?
|
Xenopus laevis | 2 | 2004 | 957 | 0.080 |
Why?
|
Cell Death | 4 | 2013 | 1707 | 0.080 |
Why?
|
Immunoglobulin Fragments | 2 | 2004 | 84 | 0.080 |
Why?
|
Silent Information Regulator Proteins, Saccharomyces cerevisiae | 1 | 2007 | 65 | 0.080 |
Why?
|
Carbon-Carbon Double Bond Isomerases | 1 | 2007 | 5 | 0.080 |
Why?
|
History, 21st Century | 1 | 2013 | 1534 | 0.080 |
Why?
|
Fatty Liver | 1 | 2013 | 727 | 0.080 |
Why?
|
Enoyl-CoA Hydratase | 1 | 2007 | 11 | 0.080 |
Why?
|
Fasting | 2 | 2010 | 1592 | 0.080 |
Why?
|
Acetyl-CoA C-Acyltransferase | 1 | 2007 | 22 | 0.080 |
Why?
|
Sequence Analysis, Protein | 1 | 2008 | 258 | 0.070 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 407 | 0.070 |
Why?
|
3-Hydroxyacyl CoA Dehydrogenases | 1 | 2007 | 60 | 0.070 |
Why?
|
Chromosome Deletion | 5 | 2001 | 1401 | 0.070 |
Why?
|
Gene Library | 3 | 2016 | 1074 | 0.070 |
Why?
|
Electrophoretic Mobility Shift Assay | 2 | 2004 | 300 | 0.070 |
Why?
|
Animals, Newborn | 5 | 2004 | 2726 | 0.070 |
Why?
|
Endodeoxyribonucleases | 2 | 2021 | 165 | 0.070 |
Why?
|
Transduction, Genetic | 1 | 2010 | 913 | 0.070 |
Why?
|
Precipitin Tests | 2 | 2008 | 829 | 0.070 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2007 | 186 | 0.070 |
Why?
|
S Phase | 2 | 2005 | 423 | 0.070 |
Why?
|
Racemases and Epimerases | 1 | 2007 | 113 | 0.070 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2010 | 372 | 0.070 |
Why?
|
Aspartic Acid | 1 | 2008 | 576 | 0.070 |
Why?
|
3' Flanking Region | 2 | 2002 | 15 | 0.070 |
Why?
|
Leukemia | 3 | 2011 | 1510 | 0.070 |
Why?
|
Nucleic Acid Hybridization | 8 | 1992 | 1375 | 0.070 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2007 | 373 | 0.070 |
Why?
|
Hippocampus | 1 | 2018 | 3675 | 0.070 |
Why?
|
Mitochondria, Muscle | 1 | 2007 | 171 | 0.070 |
Why?
|
Animals, Genetically Modified | 1 | 1991 | 1549 | 0.070 |
Why?
|
Oxidative Stress | 3 | 2008 | 3084 | 0.070 |
Why?
|
Green Fluorescent Proteins | 4 | 2010 | 2088 | 0.070 |
Why?
|
Deoxyribonucleases | 3 | 2016 | 214 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2009 | 4424 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-abl | 2 | 1996 | 146 | 0.060 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 2 | 1997 | 318 | 0.060 |
Why?
|
Genomic Library | 3 | 1996 | 193 | 0.060 |
Why?
|
Intermediate Filament Proteins | 1 | 2006 | 269 | 0.060 |
Why?
|
Biopolymers | 2 | 2003 | 189 | 0.060 |
Why?
|
Cell Nucleus | 5 | 2004 | 2969 | 0.060 |
Why?
|
Crosses, Genetic | 3 | 2008 | 791 | 0.060 |
Why?
|
Colitis | 3 | 2007 | 1170 | 0.060 |
Why?
|
Receptor Aggregation | 2 | 2003 | 80 | 0.060 |
Why?
|
Neutropenia | 1 | 2010 | 895 | 0.060 |
Why?
|
Brain Mapping | 1 | 2020 | 6670 | 0.060 |
Why?
|
Antisense Elements (Genetics) | 1 | 2004 | 37 | 0.060 |
Why?
|
Microscopy, Fluorescence | 4 | 2009 | 2700 | 0.060 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2005 | 166 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2017 | 2938 | 0.060 |
Why?
|
Retinoblastoma Protein | 1 | 2008 | 705 | 0.060 |
Why?
|
Sequence Homology | 1 | 2004 | 203 | 0.060 |
Why?
|
Gene Dosage | 2 | 2007 | 1252 | 0.060 |
Why?
|
Encephalomyocarditis virus | 1 | 2003 | 20 | 0.060 |
Why?
|
Cardiovirus Infections | 1 | 2003 | 19 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2703 | 0.060 |
Why?
|
HEK293 Cells | 3 | 2021 | 4208 | 0.060 |
Why?
|
Immune Tolerance | 2 | 2010 | 2259 | 0.060 |
Why?
|
Tubulin | 1 | 2008 | 695 | 0.060 |
Why?
|
Neoplasms, Multiple Primary | 1 | 1988 | 604 | 0.060 |
Why?
|
Base Composition | 2 | 2003 | 293 | 0.060 |
Why?
|
Wiskott-Aldrich Syndrome Protein Family | 1 | 2003 | 37 | 0.060 |
Why?
|
Leukemia, B-Cell | 1 | 2004 | 86 | 0.060 |
Why?
|
Protein Isoforms | 3 | 2003 | 1730 | 0.060 |
Why?
|
Immune System Diseases | 2 | 2002 | 261 | 0.060 |
Why?
|
Hybrid Cells | 4 | 1995 | 441 | 0.060 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2004 | 245 | 0.060 |
Why?
|
Extrachromosomal Inheritance | 1 | 2003 | 19 | 0.060 |
Why?
|
Cyclin-Dependent Kinases | 3 | 2002 | 671 | 0.060 |
Why?
|
Mitomycin | 1 | 2004 | 259 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2001 | 323 | 0.060 |
Why?
|
TATA Box | 1 | 2003 | 128 | 0.060 |
Why?
|
Templates, Genetic | 1 | 2003 | 211 | 0.060 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 2 | 1995 | 43 | 0.060 |
Why?
|
Recombinant Proteins | 6 | 2004 | 6621 | 0.050 |
Why?
|
Embryonic Development | 1 | 2008 | 711 | 0.050 |
Why?
|
Pseudopodia | 1 | 2003 | 172 | 0.050 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2017 | 1596 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 2 | 2015 | 193 | 0.050 |
Why?
|
Death | 1 | 2007 | 678 | 0.050 |
Why?
|
RNA, Neoplasm | 4 | 1992 | 769 | 0.050 |
Why?
|
NFATC Transcription Factors | 6 | 2002 | 381 | 0.050 |
Why?
|
Osteosarcoma | 1 | 2008 | 881 | 0.050 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2015 | 1378 | 0.050 |
Why?
|
Cell Line, Tumor | 6 | 2018 | 16690 | 0.050 |
Why?
|
Pre-B Cell Receptors | 1 | 2002 | 3 | 0.050 |
Why?
|
DNA Methylation | 3 | 2013 | 4285 | 0.050 |
Why?
|
Receptor, Notch1 | 1 | 2005 | 502 | 0.050 |
Why?
|
Immunologic Capping | 2 | 2000 | 31 | 0.050 |
Why?
|
Abnormalities, Multiple | 1 | 2010 | 1416 | 0.050 |
Why?
|
Fertility | 2 | 2004 | 781 | 0.050 |
Why?
|
Fetus | 6 | 1990 | 1880 | 0.050 |
Why?
|
Myelopoiesis | 1 | 2003 | 133 | 0.050 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 4 | 2016 | 1115 | 0.050 |
Why?
|
Kidney Neoplasms | 3 | 1988 | 4262 | 0.050 |
Why?
|
In Situ Nick-End Labeling | 2 | 2000 | 644 | 0.050 |
Why?
|
Listeria | 1 | 2001 | 27 | 0.050 |
Why?
|
Platelet-Derived Growth Factor | 2 | 2001 | 625 | 0.050 |
Why?
|
Feedback | 1 | 2006 | 795 | 0.050 |
Why?
|
Fatty Acids | 1 | 2010 | 1809 | 0.050 |
Why?
|
DNA, Neoplasm | 5 | 1992 | 1758 | 0.050 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2003 | 97 | 0.050 |
Why?
|
Methylation | 2 | 1995 | 1106 | 0.050 |
Why?
|
Kidney | 7 | 1999 | 7184 | 0.050 |
Why?
|
Cell Degranulation | 2 | 2003 | 287 | 0.050 |
Why?
|
Sialoglycoproteins | 1 | 2002 | 318 | 0.050 |
Why?
|
Receptor-CD3 Complex, Antigen, T-Cell | 2 | 1998 | 67 | 0.050 |
Why?
|
Hydrogen Peroxide | 1 | 2005 | 730 | 0.050 |
Why?
|
Syndrome | 2 | 2010 | 3252 | 0.050 |
Why?
|
Recombinases | 2 | 2012 | 67 | 0.050 |
Why?
|
Sirtuin 2 | 3 | 2007 | 97 | 0.050 |
Why?
|
Retroviridae | 4 | 2002 | 914 | 0.050 |
Why?
|
Genome, Human | 1 | 2014 | 4420 | 0.050 |
Why?
|
Developmental Disabilities | 1 | 2010 | 1456 | 0.050 |
Why?
|
Life Expectancy | 3 | 2009 | 1184 | 0.050 |
Why?
|
Phylogeny | 1 | 2008 | 2804 | 0.050 |
Why?
|
Enzyme Induction | 3 | 2004 | 475 | 0.050 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2020 | 985 | 0.050 |
Why?
|
Antigens, CD1 | 1 | 2003 | 437 | 0.050 |
Why?
|
Th2 Cells | 2 | 2004 | 1061 | 0.050 |
Why?
|
Mitosis | 1 | 2006 | 1208 | 0.050 |
Why?
|
Mice, 129 Strain | 2 | 2012 | 386 | 0.050 |
Why?
|
Cross-Linking Reagents | 1 | 2004 | 694 | 0.050 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2022 | 482 | 0.050 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 3 | 1995 | 906 | 0.050 |
Why?
|
Concanavalin A | 1 | 2000 | 191 | 0.050 |
Why?
|
Diencephalon | 1 | 2000 | 56 | 0.050 |
Why?
|
CDC2-CDC28 Kinases | 1 | 2000 | 113 | 0.050 |
Why?
|
Peptide Synthases | 1 | 2000 | 80 | 0.050 |
Why?
|
Integrins | 2 | 2002 | 846 | 0.050 |
Why?
|
Receptors, OX40 | 1 | 2020 | 43 | 0.050 |
Why?
|
Metallurgy | 1 | 2000 | 94 | 0.040 |
Why?
|
Time Factors | 6 | 2010 | 40075 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2006 | 1352 | 0.040 |
Why?
|
Autophagy | 1 | 2008 | 1297 | 0.040 |
Why?
|
Leucine Zippers | 2 | 1997 | 117 | 0.040 |
Why?
|
Rhinitis, Allergic, Perennial | 1 | 2000 | 57 | 0.040 |
Why?
|
Body Weight | 1 | 2010 | 4671 | 0.040 |
Why?
|
Pregnancy | 8 | 2008 | 29144 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2003 | 903 | 0.040 |
Why?
|
Herpesvirus 4, Human | 3 | 1989 | 1041 | 0.040 |
Why?
|
Platinum Compounds | 1 | 2000 | 96 | 0.040 |
Why?
|
Myelin Proteins | 2 | 1990 | 215 | 0.040 |
Why?
|
IgA Deficiency | 1 | 1999 | 43 | 0.040 |
Why?
|
Cullin Proteins | 1 | 2000 | 181 | 0.040 |
Why?
|
Membrane Microdomains | 1 | 2000 | 203 | 0.040 |
Why?
|
Sequence Analysis | 1 | 2000 | 256 | 0.040 |
Why?
|
Th1 Cells | 1 | 2004 | 1057 | 0.040 |
Why?
|
Interferon-gamma | 3 | 2003 | 3207 | 0.040 |
Why?
|
Spermatogenesis | 2 | 2013 | 262 | 0.040 |
Why?
|
Antibodies, Blocking | 1 | 2020 | 253 | 0.040 |
Why?
|
Ferritins | 1 | 2022 | 590 | 0.040 |
Why?
|
Dimerization | 2 | 1998 | 895 | 0.040 |
Why?
|
Mass Spectrometry | 3 | 2011 | 2204 | 0.040 |
Why?
|
Plasmacytoma | 3 | 1992 | 183 | 0.040 |
Why?
|
Gamma Rays | 2 | 1997 | 320 | 0.040 |
Why?
|
Insulin-Secreting Cells | 1 | 2006 | 892 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12262 | 0.040 |
Why?
|
Tissue Distribution | 3 | 2000 | 2327 | 0.040 |
Why?
|
Passive Cutaneous Anaphylaxis | 1 | 1998 | 35 | 0.040 |
Why?
|
Catalytic Domain | 2 | 2017 | 698 | 0.040 |
Why?
|
Doxorubicin | 1 | 2005 | 2234 | 0.040 |
Why?
|
Ubiquitins | 1 | 2000 | 384 | 0.040 |
Why?
|
Liposomes | 1 | 2022 | 759 | 0.040 |
Why?
|
Nucleic Acid Denaturation | 1 | 2018 | 111 | 0.040 |
Why?
|
Antibodies, Antinuclear | 2 | 1990 | 326 | 0.040 |
Why?
|
Congenital Abnormalities | 1 | 2003 | 707 | 0.040 |
Why?
|
Purkinje Cells | 1 | 2000 | 224 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 1998 | 318 | 0.040 |
Why?
|
Macaca | 1 | 2019 | 440 | 0.040 |
Why?
|
Genes, BRCA1 | 1 | 2002 | 781 | 0.040 |
Why?
|
Antigens, Viral | 1 | 2022 | 1035 | 0.040 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2011 | 894 | 0.040 |
Why?
|
RNA, Small Interfering | 3 | 2017 | 3505 | 0.040 |
Why?
|
Respiratory Hypersensitivity | 1 | 2000 | 274 | 0.040 |
Why?
|
Thymidine Kinase | 3 | 1989 | 290 | 0.040 |
Why?
|
Sciatic Nerve | 1 | 2021 | 607 | 0.040 |
Why?
|
Plasma Cells | 1 | 2001 | 591 | 0.040 |
Why?
|
GPI-Linked Proteins | 2 | 2016 | 435 | 0.040 |
Why?
|
Interleukin-2 | 4 | 2002 | 1904 | 0.040 |
Why?
|
Telomerase | 1 | 2003 | 730 | 0.040 |
Why?
|
Globins | 1 | 1998 | 416 | 0.040 |
Why?
|
Chromones | 2 | 2013 | 154 | 0.040 |
Why?
|
Genes, Essential | 1 | 1998 | 183 | 0.040 |
Why?
|
Genetic Engineering | 3 | 1990 | 951 | 0.040 |
Why?
|
Helix-Loop-Helix Motifs | 1 | 1997 | 96 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2018 | 8861 | 0.040 |
Why?
|
Immunoprecipitation | 2 | 2010 | 906 | 0.040 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 4 | 1995 | 1801 | 0.040 |
Why?
|
Lymphokines | 2 | 1991 | 949 | 0.040 |
Why?
|
Immunoglobulin Idiotypes | 2 | 1987 | 201 | 0.040 |
Why?
|
Leukocytes | 1 | 2005 | 2045 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 494 | 0.040 |
Why?
|
Receptors, Cell Surface | 2 | 2010 | 2865 | 0.040 |
Why?
|
Circadian Rhythm | 1 | 2008 | 2624 | 0.040 |
Why?
|
Oligopeptides | 1 | 2002 | 1189 | 0.040 |
Why?
|
Aphidicolin | 1 | 2016 | 36 | 0.040 |
Why?
|
Trinitrobenzenes | 2 | 2012 | 46 | 0.030 |
Why?
|
Autoimmune Diseases | 5 | 2000 | 2134 | 0.030 |
Why?
|
In Situ Hybridization | 3 | 1998 | 1950 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2002 | 1284 | 0.030 |
Why?
|
Immunoglobulin delta-Chains | 2 | 1998 | 7 | 0.030 |
Why?
|
Receptors, Complement | 1 | 1997 | 264 | 0.030 |
Why?
|
DNA, Fungal | 1 | 1997 | 280 | 0.030 |
Why?
|
Protein Conformation | 2 | 2017 | 4010 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2011 | 3921 | 0.030 |
Why?
|
Zygote | 1 | 1996 | 116 | 0.030 |
Why?
|
Forkhead Transcription Factors | 3 | 2010 | 1613 | 0.030 |
Why?
|
Transcription Factor AP-1 | 2 | 1994 | 317 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 2008 | 2530 | 0.030 |
Why?
|
Up-Regulation | 2 | 2010 | 4222 | 0.030 |
Why?
|
src-Family Kinases | 1 | 1998 | 551 | 0.030 |
Why?
|
Nerve Regeneration | 1 | 2021 | 788 | 0.030 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 1995 | 66 | 0.030 |
Why?
|
Platelet Count | 1 | 1998 | 780 | 0.030 |
Why?
|
Molecular Weight | 2 | 1993 | 2255 | 0.030 |
Why?
|
Gene Expression Profiling | 5 | 2011 | 9445 | 0.030 |
Why?
|
Immunoglobulin A | 1 | 1999 | 995 | 0.030 |
Why?
|
TNF Receptor-Associated Factor 3 | 1 | 2015 | 40 | 0.030 |
Why?
|
Antigens, T-Independent | 1 | 1994 | 21 | 0.030 |
Why?
|
Nervous System | 1 | 1999 | 554 | 0.030 |
Why?
|
Isoquinolines | 1 | 2017 | 366 | 0.030 |
Why?
|
Quinazolinones | 1 | 2017 | 221 | 0.030 |
Why?
|
Dysgammaglobulinemia | 1 | 1994 | 21 | 0.030 |
Why?
|
X-Rays | 1 | 1996 | 301 | 0.030 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 1998 | 697 | 0.030 |
Why?
|
Drug Resistance | 3 | 1998 | 1608 | 0.030 |
Why?
|
Amino Acid Substitution | 2 | 2010 | 1793 | 0.030 |
Why?
|
bcl-X Protein | 3 | 2002 | 411 | 0.030 |
Why?
|
Antigens | 2 | 2016 | 1466 | 0.030 |
Why?
|
Calmodulin-Binding Proteins | 1 | 1996 | 250 | 0.030 |
Why?
|
Lymph Nodes | 2 | 2013 | 3476 | 0.030 |
Why?
|
Second Messenger Systems | 1 | 1995 | 206 | 0.030 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2017 | 233 | 0.030 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2016 | 266 | 0.030 |
Why?
|
CD40 Ligand | 2 | 2011 | 526 | 0.030 |
Why?
|
Body Patterning | 1 | 1998 | 626 | 0.030 |
Why?
|
Receptors, Immunologic | 2 | 1993 | 1423 | 0.030 |
Why?
|
HeLa Cells | 3 | 2006 | 3130 | 0.030 |
Why?
|
Morpholines | 2 | 2013 | 571 | 0.030 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2014 | 126 | 0.030 |
Why?
|
Kanamycin Kinase | 1 | 1993 | 34 | 0.030 |
Why?
|
Phosphoprotein Phosphatases | 1 | 1996 | 338 | 0.030 |
Why?
|
Guanine Nucleotide Exchange Factors | 3 | 2003 | 581 | 0.030 |
Why?
|
Enzyme Inhibitors | 3 | 2017 | 3799 | 0.030 |
Why?
|
Fetal Growth Retardation | 1 | 1997 | 570 | 0.030 |
Why?
|
Cell Adhesion | 2 | 2016 | 3144 | 0.030 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2018 | 952 | 0.030 |
Why?
|
Lymphocyte Count | 3 | 2002 | 793 | 0.030 |
Why?
|
Nuclear Transfer Techniques | 1 | 2013 | 64 | 0.030 |
Why?
|
Muscle, Skeletal | 3 | 2008 | 4925 | 0.030 |
Why?
|
Gene Order | 1 | 2013 | 176 | 0.030 |
Why?
|
Molecular Biology | 1 | 1997 | 596 | 0.030 |
Why?
|
Purines | 1 | 2017 | 594 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2020 | 2377 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2018 | 714 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 1994 | 286 | 0.030 |
Why?
|
Rats | 5 | 1993 | 24252 | 0.030 |
Why?
|
Erythropoiesis | 1 | 1997 | 706 | 0.030 |
Why?
|
Jurkat Cells | 3 | 2000 | 743 | 0.030 |
Why?
|
Eye | 1 | 1997 | 729 | 0.030 |
Why?
|
Immunoblotting | 2 | 2010 | 1683 | 0.030 |
Why?
|
Adipose Tissue, Brown | 2 | 2010 | 756 | 0.030 |
Why?
|
Isoenzymes | 1 | 2017 | 1728 | 0.030 |
Why?
|
Dependovirus | 1 | 1997 | 706 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2013 | 393 | 0.030 |
Why?
|
Testis | 2 | 2008 | 804 | 0.030 |
Why?
|
Cell Membrane | 3 | 1993 | 3749 | 0.030 |
Why?
|
Ficoll | 1 | 2012 | 40 | 0.030 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2013 | 157 | 0.030 |
Why?
|
Gene Transfer Techniques | 1 | 1997 | 1225 | 0.030 |
Why?
|
Cerebral Cortex | 2 | 2000 | 5709 | 0.030 |
Why?
|
Protein Structure, Tertiary | 3 | 2007 | 3848 | 0.030 |
Why?
|
BRCA2 Protein | 1 | 1997 | 794 | 0.030 |
Why?
|
Age Factors | 3 | 1998 | 18373 | 0.030 |
Why?
|
Herpesvirus 1, Human | 1 | 1997 | 743 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2021 | 7882 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-pim-1 | 1 | 1991 | 34 | 0.030 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 1992 | 87 | 0.030 |
Why?
|
Simplexvirus | 2 | 1987 | 803 | 0.030 |
Why?
|
Cell-Free System | 1 | 1992 | 344 | 0.030 |
Why?
|
Virion | 1 | 1994 | 433 | 0.030 |
Why?
|
Cell Count | 1 | 2016 | 1856 | 0.030 |
Why?
|
Adenine | 1 | 2017 | 936 | 0.020 |
Why?
|
Neutralization Tests | 1 | 2013 | 758 | 0.020 |
Why?
|
Polysaccharides | 1 | 2018 | 1059 | 0.020 |
Why?
|
Spinal Cord | 1 | 2000 | 1810 | 0.020 |
Why?
|
Major Histocompatibility Complex | 2 | 2002 | 936 | 0.020 |
Why?
|
Occupational Diseases | 1 | 2000 | 1469 | 0.020 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 1992 | 193 | 0.020 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 1993 | 437 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2000 | 1862 | 0.020 |
Why?
|
RNA Precursors | 1 | 1992 | 209 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 2011 | 668 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2018 | 1660 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2018 | 1581 | 0.020 |
Why?
|
Phthalazines | 1 | 2013 | 363 | 0.020 |
Why?
|
Skin | 1 | 2004 | 4372 | 0.020 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 1995 | 871 | 0.020 |
Why?
|
Sarcoma | 1 | 2001 | 1897 | 0.020 |
Why?
|
B-Cell Activating Factor | 1 | 2010 | 119 | 0.020 |
Why?
|
Repetitive Sequences, Nucleic Acid | 2 | 1995 | 798 | 0.020 |
Why?
|
Models, Animal | 1 | 2017 | 2173 | 0.020 |
Why?
|
Leukemia, Lymphoid | 1 | 1990 | 315 | 0.020 |
Why?
|
Cytokines | 3 | 2004 | 7323 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 2 | 2005 | 1097 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 1990 | 427 | 0.020 |
Why?
|
Receptors, IgG | 1 | 1993 | 582 | 0.020 |
Why?
|
Thymectomy | 1 | 2010 | 191 | 0.020 |
Why?
|
Kinetics | 3 | 2002 | 6476 | 0.020 |
Why?
|
Genes, MHC Class II | 2 | 1991 | 457 | 0.020 |
Why?
|
Zinc Fingers | 1 | 2011 | 583 | 0.020 |
Why?
|
RNA, Untranslated | 1 | 2013 | 453 | 0.020 |
Why?
|
Erythrocytes | 3 | 1996 | 2455 | 0.020 |
Why?
|
Adoptive Transfer | 2 | 2002 | 844 | 0.020 |
Why?
|
Chemotaxis | 1 | 2012 | 607 | 0.020 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 1992 | 436 | 0.020 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2010 | 223 | 0.020 |
Why?
|
Carnitine | 1 | 2010 | 246 | 0.020 |
Why?
|
Viral Proteins | 1 | 1996 | 1900 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2012 | 1799 | 0.020 |
Why?
|
Body Temperature Regulation | 1 | 2010 | 252 | 0.020 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 1 | 2009 | 86 | 0.020 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2008 | 226 | 0.020 |
Why?
|
CpG Islands | 1 | 2013 | 1170 | 0.020 |
Why?
|
Piperidines | 1 | 2017 | 1602 | 0.020 |
Why?
|
Trisomy | 1 | 2010 | 266 | 0.020 |
Why?
|
Luciferases, Renilla | 1 | 2008 | 21 | 0.020 |
Why?
|
CLOCK Proteins | 1 | 2008 | 88 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2010 | 500 | 0.020 |
Why?
|
SOXB1 Transcription Factors | 1 | 2010 | 284 | 0.020 |
Why?
|
Cysteine | 1 | 1993 | 873 | 0.020 |
Why?
|
Molecular Dynamics Simulation | 1 | 2010 | 409 | 0.020 |
Why?
|
Period Circadian Proteins | 1 | 2008 | 102 | 0.020 |
Why?
|
Virus Integration | 1 | 2010 | 299 | 0.020 |
Why?
|
ARNTL Transcription Factors | 1 | 2008 | 99 | 0.020 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2008 | 83 | 0.020 |
Why?
|
Yeasts | 1 | 2008 | 284 | 0.020 |
Why?
|
Codon | 1 | 1989 | 611 | 0.020 |
Why?
|
Bromodeoxyuridine | 2 | 1987 | 322 | 0.020 |
Why?
|
Lupus Nephritis | 1 | 1991 | 310 | 0.020 |
Why?
|
Starvation | 1 | 2008 | 134 | 0.020 |
Why?
|
Calcium Signaling | 2 | 2003 | 721 | 0.020 |
Why?
|
Food Deprivation | 1 | 2007 | 116 | 0.020 |
Why?
|
Protein Biosynthesis | 2 | 1988 | 2126 | 0.020 |
Why?
|
Morphogenesis | 2 | 2007 | 751 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2008 | 429 | 0.020 |
Why?
|
Sperm Count | 1 | 2008 | 216 | 0.020 |
Why?
|
Adenosine Diphosphate Ribose | 1 | 2006 | 63 | 0.020 |
Why?
|
Teratoma | 1 | 2010 | 395 | 0.020 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2010 | 504 | 0.020 |
Why?
|
Haptens | 2 | 1998 | 166 | 0.020 |
Why?
|
Genetic Variation | 1 | 2002 | 6542 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2012 | 1364 | 0.020 |
Why?
|
Pyrazoles | 1 | 2017 | 1972 | 0.020 |
Why?
|
Cold Temperature | 1 | 2010 | 772 | 0.020 |
Why?
|
Synapses | 1 | 2016 | 1728 | 0.020 |
Why?
|
Poly A | 2 | 1983 | 185 | 0.020 |
Why?
|
Tumor Necrosis Factors | 1 | 2006 | 109 | 0.020 |
Why?
|
Rheumatoid Factor | 1 | 1986 | 188 | 0.020 |
Why?
|
Inflammation | 2 | 2003 | 10637 | 0.020 |
Why?
|
p300-CBP Transcription Factors | 1 | 2007 | 147 | 0.020 |
Why?
|
Myelin Sheath | 1 | 1990 | 652 | 0.020 |
Why?
|
Tyrosine | 2 | 2000 | 1462 | 0.020 |
Why?
|
Receptors, Glucocorticoid | 1 | 2008 | 302 | 0.020 |
Why?
|
Solubility | 1 | 2007 | 1088 | 0.020 |
Why?
|
Genetic Code | 1 | 1986 | 154 | 0.020 |
Why?
|
Bone Marrow Transplantation | 2 | 2006 | 2765 | 0.020 |
Why?
|
Chromosomes, Artificial, Yeast | 2 | 1995 | 118 | 0.020 |
Why?
|
Fas Ligand Protein | 1 | 2006 | 216 | 0.020 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2009 | 486 | 0.020 |
Why?
|
Histocompatibility Antigens | 1 | 1987 | 471 | 0.020 |
Why?
|
Alternative Splicing | 2 | 2002 | 1117 | 0.020 |
Why?
|
Chemokine CCL19 | 1 | 2005 | 35 | 0.020 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 1986 | 326 | 0.020 |
Why?
|
Virus Replication | 1 | 2013 | 2535 | 0.020 |
Why?
|
Adipose Tissue, White | 1 | 2008 | 351 | 0.020 |
Why?
|
Insulin-Like Growth Factor II | 1 | 1986 | 272 | 0.020 |
Why?
|
Histone Acetyltransferases | 1 | 2007 | 335 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2010 | 2988 | 0.020 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2008 | 434 | 0.020 |
Why?
|
Cerebellum | 2 | 2004 | 1488 | 0.020 |
Why?
|
Niacinamide | 1 | 2007 | 416 | 0.020 |
Why?
|
Pyrimidines | 1 | 2017 | 2943 | 0.020 |
Why?
|
Leishmania major | 1 | 2004 | 57 | 0.020 |
Why?
|
Electroporation | 1 | 2006 | 251 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2002 | 5445 | 0.020 |
Why?
|
Glucose | 2 | 2007 | 4398 | 0.020 |
Why?
|
Haplotypes | 1 | 1991 | 2779 | 0.020 |
Why?
|
Peripheral Nervous System Diseases | 1 | 1990 | 685 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2010 | 2184 | 0.020 |
Why?
|
Dinitrophenols | 1 | 2003 | 57 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 1985 | 862 | 0.020 |
Why?
|
Receptors, Virus | 1 | 1987 | 649 | 0.010 |
Why?
|
beta-N-Acetylhexosaminidases | 1 | 2003 | 53 | 0.010 |
Why?
|
Immunity | 1 | 2010 | 1014 | 0.010 |
Why?
|
Chemokines, CC | 1 | 2005 | 291 | 0.010 |
Why?
|
Chromosomes, Human, 1-3 | 1 | 1983 | 23 | 0.010 |
Why?
|
Calcium | 3 | 2003 | 5755 | 0.010 |
Why?
|
Organ Culture Techniques | 1 | 2006 | 813 | 0.010 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2005 | 311 | 0.010 |
Why?
|
STAT6 Transcription Factor | 1 | 2004 | 199 | 0.010 |
Why?
|
Computational Biology | 1 | 2016 | 3519 | 0.010 |
Why?
|
Phospholipase C gamma | 1 | 2003 | 128 | 0.010 |
Why?
|
Genes, cdc | 1 | 2003 | 116 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 2010 | 2027 | 0.010 |
Why?
|
Thermogenesis | 1 | 2007 | 434 | 0.010 |
Why?
|
Glutamine | 1 | 2006 | 579 | 0.010 |
Why?
|
Xenopus Proteins | 1 | 2006 | 433 | 0.010 |
Why?
|
Leishmaniasis, Cutaneous | 1 | 2004 | 124 | 0.010 |
Why?
|
Transplantation, Heterologous | 2 | 1988 | 2383 | 0.010 |
Why?
|
Type C Phospholipases | 1 | 2003 | 292 | 0.010 |
Why?
|
Antigens, CD1d | 1 | 2003 | 220 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 1997 | 315 | 0.010 |
Why?
|
Anaphase | 1 | 2003 | 120 | 0.010 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2003 | 92 | 0.010 |
Why?
|
Cytosol | 1 | 2006 | 901 | 0.010 |
Why?
|
Interleukin-3 | 1 | 2003 | 444 | 0.010 |
Why?
|
Hypoglycemia | 1 | 2010 | 861 | 0.010 |
Why?
|
Lymphocyte Cooperation | 1 | 2002 | 112 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 1980 | 5181 | 0.010 |
Why?
|
Hair Color | 1 | 2003 | 136 | 0.010 |
Why?
|
Tumor Burden | 1 | 2008 | 1915 | 0.010 |
Why?
|
Piperazines | 1 | 2013 | 2488 | 0.010 |
Why?
|
Killer Cells, Natural | 2 | 2003 | 2133 | 0.010 |
Why?
|
Infrared Rays | 1 | 2003 | 249 | 0.010 |
Why?
|
Gene Conversion | 1 | 2002 | 71 | 0.010 |
Why?
|
Triglycerides | 1 | 2010 | 2453 | 0.010 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1991 | 1520 | 0.010 |
Why?
|
Genes, Viral | 2 | 1997 | 718 | 0.010 |
Why?
|
Histamine | 1 | 2003 | 507 | 0.010 |
Why?
|
TNF Receptor-Associated Factor 1 | 1 | 2001 | 50 | 0.010 |
Why?
|
Bleomycin | 1 | 2003 | 512 | 0.010 |
Why?
|
Endopeptidases | 1 | 2005 | 772 | 0.010 |
Why?
|
Mice, Inbred NZB | 2 | 1991 | 56 | 0.010 |
Why?
|
Tacrolimus | 2 | 1996 | 743 | 0.010 |
Why?
|
Absorptiometry, Photon | 1 | 2008 | 1725 | 0.010 |
Why?
|
Blood Vessels | 1 | 2007 | 1125 | 0.010 |
Why?
|
Fetal Proteins | 1 | 1981 | 94 | 0.010 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2005 | 584 | 0.010 |
Why?
|
Superantigens | 1 | 2001 | 129 | 0.010 |
Why?
|
Cytoplasm | 1 | 2006 | 1536 | 0.010 |
Why?
|
Immunization, Passive | 1 | 2003 | 623 | 0.010 |
Why?
|
Alum Compounds | 1 | 2000 | 33 | 0.010 |
Why?
|
gamma-Globulins | 1 | 2000 | 124 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2000 | 1369 | 0.010 |
Why?
|
Interleukin-12 | 1 | 2003 | 580 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2008 | 2715 | 0.010 |
Why?
|
Asthma | 1 | 2000 | 6010 | 0.010 |
Why?
|
Cyclin A | 1 | 2000 | 60 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 1984 | 748 | 0.010 |
Why?
|
Genetic Linkage | 1 | 1986 | 2421 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2017 | 4839 | 0.010 |
Why?
|
Genetic Markers | 1 | 2007 | 2634 | 0.010 |
Why?
|
Serum Albumin | 1 | 2003 | 675 | 0.010 |
Why?
|
Glucose Tolerance Test | 1 | 2003 | 1151 | 0.010 |
Why?
|
Polyomavirus | 1 | 2001 | 249 | 0.010 |
Why?
|
Myelin-Associated Glycoprotein | 2 | 1990 | 113 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 2000 | 119 | 0.010 |
Why?
|
Amino Acids | 1 | 2006 | 1737 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2000 | 1821 | 0.010 |
Why?
|
Neovascularization, Physiologic | 1 | 2007 | 1351 | 0.010 |
Why?
|
Interleukin-13 | 1 | 2002 | 389 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2000 | 191 | 0.010 |
Why?
|
Salts | 1 | 2000 | 65 | 0.010 |
Why?
|
Transplantation Chimera | 1 | 2002 | 613 | 0.010 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2000 | 370 | 0.010 |
Why?
|
SKP Cullin F-Box Protein Ligases | 1 | 2000 | 177 | 0.010 |
Why?
|
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1999 | 91 | 0.010 |
Why?
|
Loss of Heterozygosity | 1 | 2001 | 684 | 0.010 |
Why?
|
Heart | 1 | 1992 | 4464 | 0.010 |
Why?
|
Alopecia | 1 | 2003 | 382 | 0.010 |
Why?
|
3T3 Cells | 1 | 2000 | 1101 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2000 | 876 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 2002 | 867 | 0.010 |
Why?
|
Bronchial Hyperreactivity | 1 | 2000 | 319 | 0.010 |
Why?
|
Child, Preschool | 2 | 2013 | 41005 | 0.010 |
Why?
|
Luciferases | 1 | 2000 | 733 | 0.010 |
Why?
|
Oligonucleotides | 2 | 1991 | 572 | 0.010 |
Why?
|
COS Cells | 1 | 2000 | 1161 | 0.010 |
Why?
|
Placenta | 1 | 1987 | 1699 | 0.010 |
Why?
|
Histamine Release | 1 | 1998 | 142 | 0.010 |
Why?
|
Antineoplastic Agents | 2 | 2017 | 13693 | 0.010 |
Why?
|
Lung | 2 | 2013 | 9857 | 0.010 |
Why?
|
rho GTP-Binding Proteins | 1 | 2000 | 293 | 0.010 |
Why?
|
Glucose-6-Phosphatase | 1 | 1997 | 73 | 0.010 |
Why?
|
Skin Tests | 1 | 2000 | 613 | 0.010 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2000 | 675 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19905 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2002 | 2505 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 2000 | 709 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2008 | 4851 | 0.010 |
Why?
|
Tetrahydrofolate Dehydrogenase | 1 | 1978 | 143 | 0.010 |
Why?
|
Artifacts | 1 | 2006 | 1904 | 0.010 |
Why?
|
RNA Splicing | 1 | 1982 | 908 | 0.010 |
Why?
|
Necrosis | 1 | 2001 | 1643 | 0.010 |
Why?
|
Core Binding Factor beta Subunit | 1 | 1996 | 45 | 0.010 |
Why?
|
Inhalation Exposure | 1 | 2000 | 443 | 0.010 |
Why?
|
Lymphoproliferative Disorders | 1 | 2000 | 524 | 0.010 |
Why?
|
Transcription Factor AP-2 | 1 | 1996 | 82 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2003 | 1782 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 1997 | 574 | 0.010 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2002 | 834 | 0.010 |
Why?
|
Paired Box Transcription Factors | 1 | 1997 | 214 | 0.010 |
Why?
|
Myeloproliferative Disorders | 1 | 2003 | 606 | 0.010 |
Why?
|
Anemia | 2 | 1997 | 1503 | 0.010 |
Why?
|
ADP-ribosyl Cyclase | 1 | 1996 | 38 | 0.010 |
Why?
|
Aplysia | 1 | 1996 | 41 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2004 | 1678 | 0.010 |
Why?
|
Leukemia, T-Cell | 1 | 1996 | 104 | 0.010 |
Why?
|
Protoplasts | 1 | 1995 | 44 | 0.010 |
Why?
|
N-Glycosyl Hydrolases | 1 | 1996 | 68 | 0.010 |
Why?
|
Glycosylphosphatidylinositols | 1 | 1996 | 94 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-rel | 1 | 1995 | 71 | 0.010 |
Why?
|
Cell Transplantation | 1 | 1997 | 477 | 0.010 |
Why?
|
Rabbits | 2 | 1995 | 4894 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2007 | 3188 | 0.010 |
Why?
|
Calcineurin | 1 | 1996 | 226 | 0.010 |
Why?
|
Isoelectric Focusing | 1 | 1994 | 181 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2003 | 2504 | 0.010 |
Why?
|
Bone Density | 1 | 2008 | 3468 | 0.010 |
Why?
|
Cell Extracts | 1 | 1995 | 138 | 0.010 |
Why?
|
Movement | 1 | 2002 | 1471 | 0.010 |
Why?
|
Immunoglobulin Light Chains, Surrogate | 1 | 1994 | 6 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2007 | 3486 | 0.010 |
Why?
|
Computer Simulation | 1 | 2008 | 6194 | 0.010 |
Why?
|
Blood Cells | 1 | 1996 | 309 | 0.010 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 1996 | 345 | 0.010 |
Why?
|
Hemagglutination Tests | 1 | 1994 | 75 | 0.010 |
Why?
|
Endoplasmic Reticulum | 1 | 2000 | 1146 | 0.010 |
Why?
|
Autoimmunity | 1 | 2002 | 1350 | 0.010 |
Why?
|
Lens, Crystalline | 1 | 1996 | 388 | 0.010 |
Why?
|
GATA2 Transcription Factor | 1 | 1994 | 161 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2000 | 1783 | 0.010 |
Why?
|
Eye Neoplasms | 1 | 1996 | 312 | 0.010 |
Why?
|
Ovalbumin | 1 | 1996 | 719 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11366 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2005 | 2725 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2003 | 3203 | 0.010 |
Why?
|
Child | 2 | 2013 | 77709 | 0.010 |
Why?
|
Sheep | 1 | 1996 | 1437 | 0.010 |
Why?
|
Eye Proteins | 1 | 1997 | 645 | 0.010 |
Why?
|
Interleukin-10 | 1 | 1999 | 1200 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2013 | 25628 | 0.010 |
Why?
|
Cyclosporine | 1 | 1996 | 788 | 0.010 |
Why?
|
MyoD Protein | 1 | 1993 | 151 | 0.010 |
Why?
|
Skin Diseases | 1 | 2001 | 1066 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1988 | 12961 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 1996 | 927 | 0.010 |
Why?
|
Macrophages | 2 | 1998 | 5660 | 0.010 |
Why?
|
Neutrophils | 1 | 2005 | 3721 | 0.010 |
Why?
|
Terpenes | 1 | 1992 | 98 | 0.010 |
Why?
|
Megakaryocytes | 1 | 1996 | 545 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1997 | 1213 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1993 | 1157 | 0.010 |
Why?
|
Infant | 1 | 2013 | 35134 | 0.010 |
Why?
|
Lectins, C-Type | 1 | 1995 | 589 | 0.010 |
Why?
|
Wound Healing | 1 | 2003 | 2785 | 0.010 |
Why?
|
Insulin | 1 | 2006 | 6582 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2000 | 1901 | 0.010 |
Why?
|
Disease Progression | 1 | 2008 | 13286 | 0.010 |
Why?
|
Methotrexate | 1 | 1978 | 1728 | 0.010 |
Why?
|
Ligands | 1 | 1998 | 3282 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2003 | 2104 | 0.010 |
Why?
|
Carcinogens | 1 | 1992 | 466 | 0.010 |
Why?
|
Mice, Inbred ICR | 1 | 1988 | 352 | 0.000 |
Why?
|
Muscle Proteins | 1 | 1993 | 1158 | 0.000 |
Why?
|
Deoxyribonuclease HindIII | 1 | 1987 | 15 | 0.000 |
Why?
|
Deoxyribonuclease EcoRI | 1 | 1987 | 31 | 0.000 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2007 | 15520 | 0.000 |
Why?
|
Hot Temperature | 1 | 1993 | 1356 | 0.000 |
Why?
|
Reference Values | 1 | 1994 | 4982 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1996 | 10943 | 0.000 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1991 | 1475 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 2000 | 12244 | 0.000 |
Why?
|
Arthritis, Rheumatoid | 1 | 2001 | 3712 | 0.000 |
Why?
|
Cell Communication | 1 | 1992 | 1621 | 0.000 |
Why?
|
Cross Reactions | 1 | 1986 | 841 | 0.000 |
Why?
|
Hemorrhage | 1 | 1996 | 3461 | 0.000 |
Why?
|
Pedigree | 1 | 1991 | 4642 | 0.000 |
Why?
|
Neoplasm Transplantation | 1 | 1987 | 2086 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2004 | 17446 | 0.000 |
Why?
|
Immunosuppressive Agents | 1 | 1996 | 4153 | 0.000 |
Why?
|
Adult | 2 | 2000 | 214052 | 0.000 |
Why?
|
Adolescent | 1 | 2010 | 85779 | 0.000 |
Why?
|
Stress, Physiological | 1 | 1988 | 1403 | 0.000 |
Why?
|
Peptides | 1 | 1993 | 4410 | 0.000 |
Why?
|
Survival Analysis | 1 | 1994 | 10252 | 0.000 |
Why?
|
Polymorphism, Genetic | 1 | 1991 | 4328 | 0.000 |
Why?
|
Collagen | 1 | 1988 | 2688 | 0.000 |
Why?
|
Cohort Studies | 1 | 2000 | 40559 | 0.000 |
Why?
|
Prospective Studies | 1 | 2000 | 53290 | 0.000 |
Why?
|
Gestational Age | 1 | 1981 | 3493 | 0.000 |
Why?
|